12 results
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... Points #EBM #Neuro #IM ... #Fremanezumab # ... Migraine #CGRP # ... #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Primary and Secondary End Points #EBM #Neuro
Fremanezumab for ... Points #EBM #Neuro #IM ... #Fremanezumab # ... Migraine #CGRP # ... CalcitoninGeneRelatedPeptideAntibody #NEJM
Fremanezumab for the Preventive Treatment of Chronic Migraine - Adverse Events in the Safety Population, According
Fremanezumab for ... Group #EBM #Neuro #IM ... #Fremanezumab # ... Migraine #CGRP # ... #NEJM
A 48-year-old-man presented to the dermatology clinic with a whitish discoloration and hyperkeratosis of the first
the dermatology clinic ... #Clinical #IM #InfectiousDisease ... RapidProgression #NEJM
Romosozumab or Alendronate for Fracture Prevention in Women with Osteoporosis - Incidence of New Vertebral, Clinical,
New Vertebral, Clinical ... PrimaryCare #Endo #IM ... #Alendronate #NEJM
A 27-year-old man with a 2-year history of recurrent, painful skin lesions. A diagnosis of hidradenitis
#Clinical #Derm ... #IM #Hidradenitis ... HidradenitisSuppurativa #NEJM
Immunosuppressive Strategies for the Prevention or Treatment of Acute GVHD. Panel A shows several classic immunosuppressive
are in routine clinical ... been tested in clinical ... Pathophysiology #IM ... Immunosuppression #NEJM
Chest radiography showed perihilar opacities in both lungs with free air in the mediastinum (Panel A,
#Clinical #PCC # ... IM #EM #Pneumomediastinum ... #Influenza #NEJM
An oral examination revealed gingival hyperplasia with a granular and hemorrhagic appearance typical of “strawberry gingivitis.”
#Clinical #IM #Rheum ... GingivalHyperplasia #NEJM
Dual Antithrombotic Therapy with Dabigatran after PCI in Atrial Fibrillation (RE-DUAL PCI trial) - Shown is
point of major or clinically ... EBM #Cardiology #IM ... AtrialFibrillation #NEJM